Amgen Announces Award for Science Teaching Excellence in Rhode Island

                       A Statewide Call for Nominations
                   Nominations Deadline: February 29, 2004

WEST GREENWICH, R.I., Jan. 5 -- Amgen Inc. (Nasdaq: AMGN), the world's largest biotechnology company, today announced it has begun accepting nominations for the 2004 Amgen Award for Science Teaching Excellence in Rhode Island, the company's statewide recognition program for science education. Two K-12 educators who work in either public or private schools in Rhode Island will each receive an unrestricted $10,000 award from Amgen, and statewide recognition, at a special award ceremony in May.

The Amgen Award for Science Teaching Excellence in Rhode Island was launched last year. Amgen also conducts similar programs in California; Colorado; Louisville, Kentucky; Boston and Cambridge, Massachusetts; Puerto Rico; and Seattle, Washington.

Anyone can nominate an educator who teaches science. The nomination letter should include: the full name of the teacher; the name and address of the school; the name of the school district; the school's phone number; the grade level taught by the science teacher; the nominator's relationship to the science teacher; the nominator's phone number; and a description of why the science teacher deserves the award, including the teacher's attributes in the areas of creativity, effectiveness, best practice development, and instructional and motivational ability.

Letters should be sent to: Amgen Award for Science Teaching Excellence, Amgen Inc., Attn: Gail Davis, Amgen Rhode Island, 40 Technology Way, West Greenwich, RI, 02817. Nominations can also be submitted electronically, at www.Amgen.com/ScienceTeacherAward/. Nominations for the award will be accepted immediately, through February 29, 2004.

Amgen is a leading global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.

CONTACT: Larry Bernard (401) 392-1683

                   Amgen, Corporate Communications